Return on Equity: The amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested. Calculated as: Income from Continuing Operations / Total Common Equity
BRIACELL THERAP (BCTX) had Return on Equity of 183.68% for the most recently reported fiscal year, ending 2024-07-31.
Income Statement Financials | |
-- |
|
$-4.79M |
|
-- |
|
-- |
|
$33.33M |
|
$-33.33M |
|
$28.40M |
|
$-4.93M |
|
$-4.93M |
|
$-4.93M |
|
$-4.93M |
|
$-4.93M |
|
$-4.93M |
|
$-33.33M |
|
$-33.25M |
|
1.10M |
|
1.10M |
|
$-4.35 |
|
$-4.35 |
|
Balance Sheet Financials | |
$3.65M |
|
$0.39M |
|
$2.22M |
|
$5.87M |
|
$7.46M |
|
-- |
|
$1.10M |
|
$8.56M |
|
$-2.68M |
|
$-2.88M |
|
$-2.68M |
|
1.22M |
|
Cash Flow Statement Financials | |
$-24.13M |
|
$-0.68M |
|
$4.42M |
|
$21.25M |
|
$0.86M |
|
$-20.39M |
|
$1.80M |
|
-- |
|
-- |
|
Fundamental Metrics & Ratios | |
0.49 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-24.58M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
Return on Equity |
183.68% |
170.95% |
|
-83.98% |
|
183.68% |
|
$-2.20 |
|
$-22.40 |
|
$-21.98 |